Register | Print Page | Contact Us | Report Abuse | Sign In
2025 State Policy Plan

2025 - 2026 State Policy Plan

Accelerating Delaware's Life Science Leadership

Delaware’s thriving life science ecosystem includes pharmaceutical and biotechnology firms, instrumentation, medical device and diagnostic companies, research, development and manufacturing firms, agricultural biotech, hospital and academic research institutes, and an array of essential business service providers. The sector’s significant recent growth has been fueled by new company formation, strategic investments in key sites and facilities, and the expansion of major global employers. Today, the sector directly supports more than 12,000 jobs across research and development, manufacturing, medical devices, biotechnology, and pharmaceutical production, with thousands more high-value jobs in construction, industrial services, law, accounting, consulting and other fields critical to the industry’s success.

All this activity serves as a source of unrivaled economic value and future opportunity for our state and most importantly, a transformational impact on public health and countless individual lives. However, unique among industries, the research, development and successful manufacturing of life science products and technologies requires immense time, study and investment over many years.

Therefore, to fortify and accelerate this growth – and enhance Delaware’s posture in a competitive regional and indeed international market – it is essential the state continue to advance a visionary strategy focused on supporting the dedicated Delaware scientists who devote their lives to bringing biomedical innovation to patients in need.

This document lays out a series of recommendations and considerations organized around these core objectives:
     • Capital - Sparking and attracting life science innovation and investment
     • Talent - Transforming our STEM workforce
     • Infrastructure - Enhancing and integrating state economic & workforce development efforts
     • Access - Expanding patient access to innovation and reducing costs

These recommendations align perfectly with priorities articulated by Governor Meyer and the General Assembly including investing in STEM education and community quality of life, expanding economic opportunities for all and ensuring access to affordable, state-of-the-art healthcare. Where funding is recommended, we believe these goals can be achieved through smart reallocation, prioritization and more effective targeting of current resources.

Key Priorities:

Capital

R&D activities that advance and facilitate the commercialization of life science innovations are essential to the sector’s long-term growth and the state should be creative and targeted with programs and incentives that boost this activity while providing optimum taxpayer ROI. These efforts play a critical role in fostering groundbreaking research, attracting top-tier talent to our research universities and institutes and companies of all sizes, encouraging the establishment and growth of innovative companies and positioning Delaware as a leader in this high-value industry. Learn More

Talent

Delaware’s unique combination of collaboration and adaptability can position it as a national leader in fostering productive workforce partnerships between industry, government, and educational institutions. This ecosystem is essential for developing a world class STEM talent pipeline to meet the evolving demands of the life sciences sector. Learn More

Infrastructure

Delaware’s intimate science and technology community provides a unique opportunity to drive economic growth by aligning and leveraging key capabilities in science, business and cutting-edge areas like cell and gene therapy, biomanufacturing and AI. The state’s economic development framework should facilitate that alignment while offering a cohesive and efficient system for businesses to access resources, navigate state programs and foster innovation. To remain competitive, the state’s economic development infrastructure should reflect the speed and agility required by dynamic industries like life sciences, manufacturing and technology. Further, Delaware’s economic strategy and advocacy efforts would benefit from a clear points of contact and accountability within the executive administration. Learn More

Access

Delaware life science researchers and workers devote their lives to bringing innovative medicines and other technologies to patients. We must expand access to these life-saving treatments and diagnostics and reduce unnecessary costs by: lowering costs for patients, increasing access, ensuring transparency, investing in health IT and telemedicine, promoting biotech solutions for preventative care, and including industry in public health initiatives.   Learn More

Download Report Contact Us

"Unique among industries, the research, development and successful manufacturing of life science products and technologies requires immense time, study and investment over many years,” said Fleming. “To ensure our continued growth – and enhance Delaware’s posture in a competitive regional and indeed international market – it is essential the state advance a strategy focused on common-sense proposals that drive continued life science innovation and investment and support the dedicated Delaware scientists who devote their lives to bringing biomedical innovation to patients in need.”

Michael Fleming
PRESIDENT & CEO, DELAWARE BIOSCIENCE ASSOCIATION

Stay Up To Date
Sign up to receive our newsletter, upcoming event notifications, and industry news
Sign Up Now

Our Sponsors